Entourage Health signs agreement with Irwin Naturals to produce products in Canada
August 4, 2022 By Haley Nagasaki
(Globe Newswire) Toronto — Entourage Health Corp., a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that it has entered into an exclusive licensing, manufacturing and distribution agreement with Irwin Naturals Inc., a renowned nutraceuticals and herbal supplement formulator of popular branded wellness products sold across North America.
The new line of CBD and THC products will be produced under the agreement, and curated by Entourage alongside Irwin’s wholly owned subsidiary Irwin Naturals Cannabis. They are expected to launch on Entourage’s Starseed Medicinal channel in Q4, 2022, with eventual expansion into retail markets across Canada.
“This is a timely partnership that brings together Irwin Naturals, a trusted leader in the nutraceuticals wellness market for close to three decades, and Entourage as one of the first licensed producers to expand its cannabis products into the self-care medical market.” — George Scorsis, Executive Chairman and CEO, Entourage
Under the terms of the agreement, Entourage will manufacture the newly formulated suite of Irwin-branded line of softgels in five different varieties: CBD, THC and three additional formulations that include both THC and another cannabinoid.
In light of recent recommendations issued by Health Canada’s Science Advisory Committee on Health Products Containing Cannabis, the Irwin-branded CBD products could eventually launch over-the-counter in pharmacies across Canada.
“Irwin Naturals needs no introduction. The history of its products, the loyalty they’ve inspired, speak for themselves in health and wellness. Adding our expertise in the cannabis space creates a game-changing pairing that will put the Irwin Naturals brand on dispensary shelves all across Canada.” — George Scorsis, CEO and Executive Chairman of Entourage
Print this page